Peri-implantitis is often informally compared to periodontal disease developing around an implant. This comparison is understandable, but incomplete. Although periodontitis and peri-implantitis share the involvement of bacterial biofilm and a chronic host inflammatory response, the tissues surrounding an implant differ from those around a natural tooth. Different anatomy, altered soft tissue organization, the absence of the periodontal ligament, implant surface characteristics, and limited regenerative capacity mean that inflammation around an implant may progress more dynamically and lead to faster bone loss.
In clinical practice, comparing periodontitis and peri-implantitis is natural. In both conditions, bacterial biofilm is the starting point, initiating a local immune response. In both diseases, chronic inflammation develops, pro-inflammatory mediators are activated, and tissue-destructive processes are triggered. In both cases, oral hygiene, plaque control, local factors, smoking, systemic diseases, and the patient’s susceptibility to an unfavorable inflammatory response are relevant.
However, these similarities do not fully explain the problem. Peri-implantitis is not simply periodontitis transferred onto an implant. An implant is not a tooth, and peri-implant tissues are not identical to periodontal tissues. This difference has important implications for the course of inflammation, the rate of bone loss, and the predictability of treatment.
Around a natural tooth, the periodontal ligament is present — a specialized connective tissue structure with mechanical, biological, and sensory functions. Around an implant, this structure does not exist. The connection between the implant and bone is based on osseointegration, while the organization of the soft tissues around the implant is different. In practical terms, this means that the tissue barrier around an implant may be less resistant to chronic inflammatory infiltration, and the inflammatory process may spread more easily toward the bone.
This is one of the reasons why peri-implantitis may follow a more aggressive course than classical periodontitis. Descriptions of peri-implant tissue diseases emphasize that peri-implantitis may involve a more extensive inflammatory infiltrate, faster bone loss, and a more limited regenerative capacity of the tissues. From the clinician’s perspective, this means that even seemingly minor signs of inflammation around an implant should not be underestimated. In this disease, timing matters.
In periodontitis, tissue destruction often develops over many years, although the rate of progression can vary considerably. In peri-implantitis, bone loss may progress faster and in a less predictable manner. This does not always have to result from a greater amount of biofilm. Sometimes the decisive factor is how the patient’s body responds to the biofilm and to the local conditions around the implant. This is why peri-implantitis is increasingly analyzed as a multifactorial disease, rather than merely as a consequence of insufficient hygiene.
The immune response plays a key role in this process. Bacteria present in the biofilm trigger an inflammatory reaction involving numerous immune cells and pro-inflammatory mediators. Cytokines such as IL-1β, IL-6, and TNF-α are particularly important. Their increased activity may enhance osteoclastogenesis — the formation and activation of cells responsible for bone resorption. As a result, a chronic inflammatory response not only damages soft tissues, but also shifts bone balance toward the loss of support for the implant.
This immunological and bone-related mechanism explains how local inflammation around an implant can quickly become a structural problem. If inflammation persists and the mechanisms responsible for resolving the inflammatory response are insufficient, bone destruction may progress even in the absence of significant pain. For the patient, peri-implantitis may therefore remain relatively silent for a long time, while for the clinician, clinical and radiological examination may already reveal signs of increasing risk.
Another important factor distinguishing peri-implantitis from periodontitis is the implant surface. Implant surfaces are designed to support osseointegration, but their microstructure may also favor biofilm retention, especially when the surface becomes exposed as a result of bone loss or soft tissue recession. The more difficult it is to effectively decontaminate the implant surface, the greater the risk that the local inflammatory stimulus will persist. In advanced peri-implantitis, achieving mechanical and biological control of the implant surface may be significantly more challenging than treating the root surface of a natural tooth in periodontal disease.
Prosthetic and biomechanical factors are also important. Prosthetic misfit, overload, unfavorable emergence profile, limited access for hygiene, cement remnants, or restorations that promote plaque accumulation may all intensify the inflammatory process. In periodontitis, the anatomy of the tooth and periodontium provides the biological reference point. In implant dentistry, however, the environment around the implant is largely shaped by surgical and prosthetic decisions. This means that the risk of peri-implantitis is related not only to the patient and the biofilm, but also to the design of the entire treatment.
Differences also concern regenerative potential. Tissues around natural teeth and tissues around implants respond differently to injury, treatment, and attempts at reconstruction. In peri-implantitis, regeneration of lost tissues is often difficult, and treatment predictability may be limited. This is why early diagnosis and regular monitoring are particularly important. Treating advanced destruction around an implant is far more difficult than controlling the disease at an earlier stage.
At this point, a practical question arises: what should particularly attract the clinician’s attention? The presence of an implant itself requires systematic assessment of peri-implant tissues. Bleeding on probing, increasing probing depth, radiographic bone loss, suppuration, changes in soft tissue contour, hygiene difficulties, or a history of periodontal disease should all be considered as part of a broader risk assessment. In peri-implantitis, it is not advisable to wait for symptoms that the patient will recognize as alarming, because the disease may progress without clear pain.
A previous history of periodontitis is especially important. Patients with a history of periodontal disease are at increased risk of peri-implant tissue diseases. This is not only due to microbial similarities. Persistent susceptibility to an excessive inflammatory response, possible dysbiosis, previous attachment and bone loss, and the need for long-term supportive care are also relevant. An implant placed in a patient with a history of periodontitis does not “reset” the biology of the oral cavity. In many cases, it requires even more consistent monitoring than natural dentition.
It is also important to remember that peri-implantitis may be modified by the patient’s systemic condition. Diabetes, cardiovascular disease, obesity, metabolic syndrome, osteoporosis, or autoimmune disorders may influence the inflammatory response, healing, bone metabolism, and susceptibility to disease progression. This does not mean that any of these diseases automatically leads to implant loss. It does mean, however, that in some patients local inflammation around an implant develops in an organism that is already functioning in a state of altered inflammatory or metabolic balance.
From this perspective, peri-implantitis is a disease that requires anticipatory thinking. When a clinician diagnoses peri-implant mucositis, it should not be treated as a minor, reversible episode without consequences. Yes, mucositis may be reversible, but it is also a signal that the peri-implant environment has entered an inflammatory phase. In a patient with additional risk factors, the boundary between soft tissue inflammation and bone loss may be crossed faster than expected based on experience with periodontitis.
This is why contemporary education in peri-implantitis should emphasize the differences between a tooth and an implant. Implant dentistry does not end once osseointegration is achieved and the prosthetic restoration is delivered. Long-term success depends on maintaining biological stability around the implant. This stability requires biofilm control, appropriate prosthetic design, proper supportive care, systemic risk assessment, and early response to the first signs of inflammation.
In this sense, the question of why peri-implantitis may progress faster than periodontitis leads to a broader conclusion: an implant is not biologically identical to a tooth, and peri-implant tissues have their own specific response to chronic inflammatory stimuli. Peri-implantitis develops in an environment where biofilm, implant surface, host immune response, prosthetic factors, and the patient’s systemic condition intersect.
The role of the PERI-EDU project is to organize this knowledge and translate it into modern educational materials for students, academic teachers, and dental professionals. Understanding the differences between periodontitis and peri-implantitis is not merely theoretical. It is the basis for earlier diagnosis, better risk assessment, and more informed long-term management of implant patients.
Peri-implantitis may progress faster because it develops in a different biological environment than periodontal disease around a natural tooth. If we want to improve the predictability of implant treatment, we must look not only at the presence of biofilm, but also at the tissues, the implant, the prosthetic design, and the patient as a whole. This way of thinking may become one of the most important elements of modern implant education and clinical practice.